Skip to main content

Table 1 Patient characteristics

From: Prevalence, patterns, and impact of myofascial pain in patients with head and neck cancer after cancer treatment - a single-center cross-sectional study in India

 

% (n)

Total patients

100 (n = 120)

Males

84.2 (n = 101)

Females

15.8 (n = 19)

Age (in years)

 

Range

24–81

Mean

55.91

Standard deviation

11.706

18–24 years

0.8 (n = 1)

25–44 years

16.7 (n = 20)

45–60 years

45 (n = 54)

61–75 years

35 (n = 42)

76–90 years

2.5 (n = 3)

Occupation

 

Skilled

5.8 (n = 7)

Unskilled

65.8 (n = 79)

Unemployed

28.4 (n = 34)

Comorbidity

 

No comorbidity

60.0 (n = 72)

Single comorbidity

21.7 (n = 26)

Multimorbidity

18.3 (n = 22)

Head and neck cancer diagnosis site

 

Oral cavity

64.1 (n = 77)

Oropharynx

11.7 (n = 14)

Hypopharynx

10.0 (n = 12)

Larynx

12.5 (n = 15)

Others (nasopharynx/paranasal sinus/salivary glands)

1.7 (n = 2)

Stage of malignancy

 

Non-metastatic

94.2 (n = 113)

Metastatic

5.8 (n = 7)

Treatment received

 

Surgery

4.2 (n = 5)

Surgery + Adjuvant treatment (RT/CTRT)

57.5 (n = 69)

Definitive treatment (RT/CTRT)

37.5 (n = 45)

Palliative RT

0.8 (n = 1)

Dose of CTRT

n = 56

70 Gy/35#

57.1 (n = 32)

66 Gy/30#

3.6 (n = 2)

66 Gy/33#

26.8 (n = 15)

Others

12.5 (n = 7)

Dose of RT

n = 59

70 Gy/35#

15.3 (n = 9)

60 Gy/30#

78.0 (n = 46)

66 Gy/33#

5.1 (n = 3)

22.5 Gy/5#

1.7 (n = 1)

Post-treatment period (months)

 

3–12

58.3 (n = 78)

13–36

29.2 (n = 35)

> 36

12.5 (n = 15)